Save The Date: November 1-2, 2017
10 on the Park, New York City

Steering Committee

  • Karen Bernstein, PhD, Co-Founder and Chairman, BioCentury Publications Inc
  • Laurence Blumberg, MD, Founder and CEO, Syntimmune, Inc.
  • Stephen Mon Wei Chang, PhD, Senior Vice President, Strategic Initiatives, The New York Stem Cell Foundation
  • Ron Cohen, MD, President & CEO, Acorda Therapeutics, Inc.
  • Barry Coller, MD, Vice President, Medical Affairs, Physician-in-Chief, The Rockefeller University
  • Ellen B. Corenswet, Partner, Covington & Burling LLP
  • Pamela Demain, MBA, Executive Director, Corporate Licensing, Merck & Co., Inc.
  • Eric Elenko, PhD, Executive Vice President, PureTech Health
  • Gerald Fischbach, MD, Scientific Director, Simons Foundation
  • Allan Goldberg, President and CEO, Avacyn Pharmaceuticals
  • Julia P. Gregory, Former CEO, ContraFect
  • Michael Gutch, PhD, Executive Director – Corporate Development, AstraZeneca
  • Kimberly Ha, Senior Director, FTI Consulting
  • Cláudia Hirawat, Chair, International Circle of Ambassadors, EURORDIS, 
  • Nouhad T. Husseini, Vice President, Business Development, Regeneron Pharmaceuticals, Inc.
  • Kenneth Kaushansky, MD, MACP, Senior Vice President, Health Sciences Dean, School of Medicine, Stony Brook University
  • Yung S. Lie, PhD, Deputy Director and CSO, Damon Runyon Cancer Research Foundation
  • Ginny Llobell, Vice President, Defined Health
  • Joel S. Marcus, Chairman, Chief Executive Officer & Founder, Alexandria Real Estate Equities, Inc/ Alexandria Venture Investments
  • Ronald Newbold, PhD, Vice President, External Research and Devlopment, Pfizer
  • Timothy J. Pelura, PhD, President and CEO, Surpass, Inc. 
  • Glenn D. Prestwich, PhD, Presidential Professor, Medicinal Chemistry, University of Utah
  • Linda M. Pullan, PhD, Principal, Pullan Consulting
  • Barbara Ryan, Founder, Barbara Ryan Advisors 
  • Charles S. Ryan, JD, PhD, Vice President, General Counsel, Cold Spring Harbor Laboratory
  • Todd Sherer, PhD, Chief Executive Officer, The Michael J. Fox Foundation for Parkinson’s Research (MJFF)
  • Mark J. Simon, Advisor, Torreya Partners 
  • Barbara S. Slusher, PhD, MAS, Direcort, Johns Hopkins Drug Discovery
  • Mary C. Tanner, Managing Director, Burrill & Company